According to a study published in JAMA Network Open, 70% of U.S. adults would conduct a home test for suspected COVID-19.

The $350 million NERB boosts the university’s ability to engage in multi-site clinical trials, targeting treatments for both rare and common diseases.

Jim FessendenUMass Chan Medical SchoolNew research by Sumeda Nandadasa, PhD, reveals how a key protein associated with Meckel-Gruber syndrome ...

Oral nicotine pouches—small, smokeless, nearly invisible and placed between the lip and gum—are rapidly gaining popularity ...

HHS Secretary RFK Jr. said he wants to encourage all Americans to use wearables to track health metrics. What are the ...

Seventy percent of U.S. adults would conduct a home test for suspected COVID-19, according to a study published online June ...

The Broad is the latest Massachusetts research hub to take cost-saving measures amid unprecedented freezes and likely ...

Critically ill children and their families are given life-changing wishes by Make-A-Wish. Disney is Make-A-Wish's largest ...

Relative to before the pandemic, the number of vaccinated participants fell 10% among children and 4% in adults in pandemic ...

Shionogi will pay BioVersys $6.3 million for developing BV500, BioVersys's drug candidate for non-tuberculous mycobacteria.

Among just over 2,000 survey respondents, 70% said they would conduct a home test if they suspected they had COVID, with ...

Lawyers, students, researchers and higher education leaders debate whether Harvard should consider a deal with the Trump ...